FDA approves generic enoxaparin sodium for US sale
Techdow USA announced the FDA approval of its generic enoxaparin sodium for marketing in the U.S.
The preservative-free anticoagulant, used to prevent and treat deep vein thrombosis, will be available in prefilled syringes, according to a company press release.
“Techdow USA is excited to bring this critical product to institutions, retail and other networks in need of a safe, affordable and reliable source of Enoxaparin,” Darren Alkins, CEO of Techdow USA, said in the release. “As a vertically integrated company in this complex environment with difficult to source raw material and state-of-the-art prefilled syringe manufacturing, our U.S. and global networks will help ensure reliable enoxaparin supply, while offering competitive pricing.”
Collapse
Read more about